Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Crispr Therapeutics Ag (CRSP)  
$51.17 2.38 (4.44%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 70,650,000
Market Cap: 3.62(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $38.62 - $89.12
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 89,721 159,721 184,721 409,721
Total Sell Value $6,558,882 $10,834,513 $12,456,407 $25,314,056
Total People Sold 3 3 3 3
Total Sell Transactions 10 12 13 22
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 483
  Page 9 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bolzon Bradley J Phd Director   –       •      –    2020-06-22 4 AS $72.51 $725,069 I/I (10,000) 584,190 20%     
   Ho Tony W Executive VP, Head of R&D   •       –      –    2020-06-22 4 AS $70.14 $16,062 D/D (229) 40,676 20%     
   Treco Douglas A Director   –       •      –    2020-06-11 3 IO $0.00 $0 D/D 0 2,000 51%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2020-06-02 4 D $66.26 $51,617 D/D (779) 170,747     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2020-06-01 4 AS $63.57 $1,117,266 D/D (17,275) 171,526 51%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2020-06-01 4 OE $1.81 $31,268 D/D 17,275 188,801     -
   Novak Rodger President   •       •      –    2020-05-26 4 AS $70.27 $2,573,006 D/D (36,616) 748,007 32%     
   Ho Tony W Executive VP, Head of R&D   •       –      –    2020-05-26 4 AS $70.14 $427,854 D/D (6,100) 40,905 32%     
   Novak Rodger President   •       •      –    2020-05-22 4 AS $70.01 $937,014 D/D (13,384) 784,623 28%     
   Ho Tony W Executive VP, Head of R&D   •       –      –    2020-05-22 4 AS $70.05 $42,030 D/D (600) 47,005 28%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2020-05-20 4 AS $65.28 $698,039 D/D (10,693) 171,526 25%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2020-05-20 4 OE $1.81 $19,354 D/D 10,693 182,219     -
   Novak Rodger President   •       •      –    2020-05-19 4 AS $65.00 $3,250,000 D/D (50,000) 798,007 46%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2020-05-19 4 AS $65.16 $280,644 D/D (4,307) 171,526 46%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2020-05-19 4 OE $1.81 $7,796 D/D 4,307 175,833     -
   Klein Lawrence Otto CBO & COO   •       –      –    2020-05-11 4 AS $60.38 $1,509,971 D/D (25,000) 20,000 39%     
   Klein Lawrence Otto CBO & COO   •       –      –    2020-05-11 4 OE $5.86 $146,500 D/D 25,000 45,000     -
   Ho Tony W Executive VP, Head of R&D   •       –      –    2020-03-06 4 D $52.64 $82,276 D/D (1,563) 47,605     -
   Ho Tony W Executive VP, Head of R&D   •       –      –    2020-03-05 4 OE $0.00 $0 D/D 3,333 49,168     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2020-03-02 4 D $52.74 $41,876 D/D (794) 171,526     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2019-12-16 4 OE $1.81 $14,480 D/D 8,000 172,320     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2019-12-01 4 D $71.65 $53,093 D/D (741) 164,320     -
   Cagnoni Pablo J Director   –       •      –    2019-11-12 4 AS $55.00 $412,500 D/D (7,500) 0     -
   Cagnoni Pablo J Director   –       •      –    2019-11-12 4 OE $5.59 $41,925 D/D 7,500 7,500     -
   Cagnoni Pablo J Director   –       •      –    2019-10-30 4 AS $52.00 $390,000 D/D (7,500) 0     -
  483 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us